Company registration number 07928078 (England and Wales)
PRINCIPAL FORENSIC TOXICOLOGY AND DRUGS CONSULTANCY LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026
PAGES FOR FILING WITH REGISTRAR
PRINCIPAL FORENSIC TOXICOLOGY AND DRUGS CONSULTANCY LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
PRINCIPAL FORENSIC TOXICOLOGY AND DRUGS CONSULTANCY LTD (REGISTERED NUMBER: 07928078)
BALANCE SHEET
AS AT 31 JANUARY 2026
31 January 2026
- 1 -
2026
2025
Notes
£
£
£
£
Fixed assets
Tangible assets
3
2,258
1,063
Current assets
Debtors
4
6,827
12,423
Cash at bank and in hand
85,641
56,552
92,468
68,975
Creditors: amounts falling due within one year
5
(15,642)
(9,005)
Net current assets
76,826
59,970
Net assets
79,084
61,033
Capital and reserves
Called up share capital
6
100
100
Profit and loss reserves
78,984
60,933
Total equity
79,084
61,033
For the financial year ended 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
The financial statements were approved by the board of directors and authorised for issue on 20 October 2026 and are signed on its behalf by:
Mrs E A Scott-Ham
Director
PRINCIPAL FORENSIC TOXICOLOGY AND DRUGS CONSULTANCY LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026
- 2 -
1
Accounting policies
Company information
Principal Forensic Toxicology And Drugs Consultancy Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 10 Upper Grosvenor Road, Tunbridge Wells, Kent, United Kingdom, TN1 2EP.
1.1
Basis of preparation
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £1.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.2
Revenue
Turnover is recognised at the fair value of the consideration received or receivable for forensic consultancy services provided in the normal course of business, and is shown net of VAT. Income is recognised at the invoice date.
1.3
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Computer equipment
33% on cost
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
1.4
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
1.5
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
PRINCIPAL FORENSIC TOXICOLOGY AND DRUGS CONSULTANCY LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
- 3 -
2
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2026
2025
Number
Number
Total
2
2
3
Tangible fixed assets
Computer equipment
£
Cost
At 1 February 2025
4,289
Additions
2,258
At 31 January 2026
6,547
Depreciation and impairment
At 1 February 2025
3,226
Depreciation charged in the year
1,063
At 31 January 2026
4,289
Carrying amount
At 31 January 2026
2,258
At 31 January 2025
1,063
4
Debtors
2026
2025
Amounts falling due within one year:
£
£
Trade debtors
6,827
12,423
PRINCIPAL FORENSIC TOXICOLOGY AND DRUGS CONSULTANCY LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
- 4 -
5
Creditors: amounts falling due within one year
2026
2025
£
£
Trade creditors
228
218
Taxation and social security
7,007
4,588
Other creditors
8,407
4,199
15,642
9,005
6
Called up share capital
2026
2025
2026
2025
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
0
100
100
Ordinary A shares of £1 each
50
0
50
Ordinary B shares of £1 each
50
0
50
100
100
100
100